| mRNA |
lapatinib |
GDSC1000 |
pan-cancer |
AAC |
0.3 |
6e-09 |
| mRNA |
PD-0325901 |
gCSI |
pan-cancer |
AAC |
0.27 |
5e-06 |
| mRNA |
Erlotinib |
GDSC1000 |
pan-cancer |
AAC |
0.24 |
6e-06 |
| mRNA |
EKB-569 |
GDSC1000 |
pan-cancer |
AAC |
0.16 |
2e-05 |
| mRNA |
Cetuximab |
GDSC1000 |
pan-cancer |
AAC |
0.16 |
3e-05 |
| mRNA |
lapatinib |
gCSI |
pan-cancer |
AAC |
0.26 |
3e-05 |
| mRNA |
selumetinib:BRD-A02303741 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.15 |
4e-05 |
| mRNA |
AZD6244 |
CTRPv2 |
pan-cancer |
AAC |
0.16 |
4e-05 |
| mRNA |
selumetinib:UNC0638 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.15 |
9e-05 |
| mRNA |
selumetinib:PLX-4032 (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.15 |
0.0001 |